Princeton, NJ, United States of America

Danielle Guarracino


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Danielle Guarracino

Introduction

Danielle Guarracino is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of science and technology, holding a total of 4 patents. Her work primarily focuses on the development of oligooxopiperazines, which have important applications in modulating protein interactions.

Latest Patents

Among her latest patents is the invention titled "Oxopiperazine helix mimetics as inhibitors of the p53-MDM2 interaction." This invention relates to oligooxopiperazines designed to modulate the p53-Mdm2 interaction, which is crucial in cancer research. The patent details various exemplary oligooxopiperazines, including those of Formula IA, Formula IB, and Formula IC, along with methods for their use. Another notable patent is "Oligooxopiperazines and methods of making and using them," which discusses the preparation and application of oligooxopiperazines.

Career Highlights

Danielle Guarracino is affiliated with New York University, where she continues to advance her research and innovation in the field. Her work has garnered attention for its potential impact on therapeutic strategies, particularly in cancer treatment.

Collaborations

Danielle has collaborated with esteemed colleagues such as Paramjit S Arora and Brooke Bullock Lao, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Danielle Guarracino's contributions to the field of oligooxopiperazines and her innovative patents highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…